NEW YORK, Dec. 10 — Genomics expert George F. Steinfels was named chief scientific officer of QED Solutions and general manager of the company's new genomics technology division, QNOME, the firm said on Monday.
With expertise in the application of genomic technologies to drug development, Steinfels will seek to improve and expand the company's Qscan dataset, which allows researchers to access drug profiles, monitor adverse drug events, analyze potential interactions, and correlate compounds with known drugs over the Internet. The new QNOME division, by comparison, is designed to use genome technology to help improve drug safety.
QED Solutions, of McLean, Va., was founded in 1998, and specializes in products that can be used to improve drug safety both for candidate drugs and approved pharmaceuticals.
Steinfels founded the consultant group Genomic Strategies and was previously chief operating officer of the pharmacogenomics business at Quintiles.